{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:26:58Z","timestamp":1777465618041,"version":"3.51.4"},"reference-count":290,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T00:00:00Z","timestamp":1268784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s12640-010-9161-7","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T15:57:35Z","timestamp":1268755055000},"page":"211-228","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment"],"prefix":"10.1007","volume":"18","author":[{"given":"Trevor","family":"Archer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Beninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"9161_CR1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0447.2006.00900.x","volume":"115","author":"J Addington","year":"2007","unstructured":"Addington J, Addington D (2007) Patterns, predictors, and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 115:304\u2013309","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/schbul\/sbl075","volume":"33","author":"J Addington","year":"2007","unstructured":"Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R, North American Prodrome Longitudinal Study (2007) North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 33:665\u2013672","journal-title":"Schizophr Bull"},{"key":"9161_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archpsyc.57.3.285","volume":"57","author":"GS Alexopoulos","year":"2000","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, Sirey JA, Hull J (2000) Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatr 57:285\u2013290","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR4","unstructured":"Allen P, Seal ML, Valli I, Fusar-Poli P, Perlini C, Day F, Wood SJ, Williams SC, McGuire PK (2009) Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis. Schizophr Bull. PMID:19933712"},{"key":"9161_CR5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.184.4.346","volume":"184","author":"S Almond","year":"2004","unstructured":"Almond S, Knapp M, Francois C, Toumi M, Brugha T (2004) Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatr 184:346\u2013351","journal-title":"Br J Psychiatr"},{"key":"9161_CR6","first-page":"1","volume":"15","author":"M Alvarez-Jim\u00e9nez","year":"2008","unstructured":"Alvarez-Jim\u00e9nez M, Gleeson JF, Cotton SM, Wade D, Crisp K, Yap MB, McGorry PD (2008) Differential predictors of critical comments and emotional over-involvement in first-episode psychosis. Psychol Med 15:1\u201310","journal-title":"Psychol Med"},{"key":"9161_CR7","doi-asserted-by":"crossref","unstructured":"Alvarez-Jim\u00e9nez M, Parker AG, Hetrick SE, McGorry PD and Gleeson JF (2009a) Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull (in press). PMID:19900962","DOI":"10.1093\/schbul\/sbp129"},{"issue":"10","key":"9161_CR8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/070674370905401008","volume":"54","author":"M Alvarez-Jim\u00e9nez","year":"2009","unstructured":"Alvarez-Jim\u00e9nez M, Gleeson JF, Cotton S, Wade D, Gee D, Pearce T, Crisp K, Spiliotacopoulos D, Newman B, McGorry PD (2009b) Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis. Can J Psychiatry 54(10):710\u2013718","journal-title":"Can J Psychiatry"},{"key":"9161_CR9","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC"},{"key":"9161_CR10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1399-5618.2008.00638.x","volume":"10","author":"S Andersson","year":"2008","unstructured":"Andersson S, Barder HE, Hellvin T, L\u00f6vdahl H, Malt UF (2008) Neuropsychological and electrophysiological indices of neurocognition in bipolar II disorder. Bipolar Disord 10:888\u2013899","journal-title":"Bipolar Disord"},{"key":"9161_CR11","first-page":"263","volume":"34","author":"AC Andreazza","year":"2009","unstructured":"Andreazza AC, Kapczinski F, Kauer-Sant\u2019Anna M, Walz JC, Bond DJ, Goncales CA, Young LT, Yatham LN (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. Neuroscience 34:263\u2013271","journal-title":"Neuroscience"},{"key":"9161_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF03033573","volume":"14","author":"T Archer","year":"2008","unstructured":"Archer T, Adolphsson B, Karlsson E (2008) Affective personality as cognitive-emotional presymptom profiles regulatory for self-reported health predispositions. Neurotox Res 14:21\u201344","journal-title":"Neurotox Res"},{"key":"9161_CR13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.1991.00400050129024","volume":"151","author":"MK Aronson","year":"1991","unstructured":"Aronson MK, Wee LO, Dalia LG, Masur D, Blau A, Frishman W (1991) Dementia: age-dependent incidence, prevalence, and mortality in the old old. Arch Intern Med 151:989\u2013992","journal-title":"Arch Intern Med"},{"key":"9161_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(95)92168-0","volume":"346","author":"MJ Arranz","year":"1995","unstructured":"Arranz MJ, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R (1995) Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346:281\u2013282","journal-title":"Lancet"},{"key":"9161_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.mp.4000348","volume":"3","author":"MJ Arranz","year":"1998","unstructured":"Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW (1998) Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatr 3:61\u201366","journal-title":"Mol Psychiatr"},{"key":"9161_CR16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatr 184:110\u2013117","journal-title":"Br J Psychiatr"},{"key":"9161_CR17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(07)60453-X","volume":"369","author":"F Benazzi","year":"2007","unstructured":"Benazzi F (2007) Bipolar disorder-focus on bipolar II disorder and mixed depression. Lancet 369:935\u2013945","journal-title":"Lancet"},{"key":"9161_CR18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00702-007-0742-4","volume":"114","author":"S Bender","year":"2007","unstructured":"Bender S, Weisbrod M, Resch F (2007) Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia. J Neural Transm 114:1199\u20131215","journal-title":"J Neural Transm"},{"key":"9161_CR19","first-page":"181","volume-title":"Handbook of the psychology of aging","author":"S Berg","year":"1996","unstructured":"Berg S (1996) Aging, behavior and terminal illness. In: Brirren JE, Schale KW (eds) Handbook of the psychology of aging, 34th edn. Academic Press, New York, pp 181\u2013197","edition":"34"},{"key":"9161_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2007.03.007","volume":"100","author":"M Berk","year":"2007","unstructured":"Berk M, Hallam KT, McGorry PD (2007) The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100:279\u2013281","journal-title":"J Affect Disord"},{"key":"9161_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.08.011","volume":"114","author":"M Berk","year":"2009","unstructured":"Berk M, Malhi GS, Hallam KT, Gama CS, Dodd S, Andreazza AC, Frey BN, Kapczinski F (2009) Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disorder 114:1\u201313","journal-title":"J Affect Disorder"},{"key":"9161_CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00406-002-0366-5","volume":"252","author":"G Bersani","year":"2002","unstructured":"Bersani G, Orlandi V, Kotzalidis GD, Pancheri P (2002) Cannabis and schizophrenia: impact on onset, course, psychopathology, and outcomes. Eur Arch Psychiatr Clin Neurosci 252:86\u201392","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"9161_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archpsyc.65.7.762","volume":"65","author":"M Bertelsen","year":"2008","unstructured":"Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlaeger J, le Quach P, Christensen TO, Krarup G, Jorgensen P, Nordentoft M (2008) Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 65:762\u2013771","journal-title":"Arch Gen Psychiatry"},{"key":"9161_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2008.09.018","volume":"107","author":"M Bertelsen","year":"2009","unstructured":"Bertelsen M, Jeppesen P, Petersen L, Thorup A, \u00d8hlenschlaeger J, Le Quach P, \u00d8stergaard Christensen T, Krarup G, J\u00f8rgensen P, Nordentoft M (2009) Course of illness in a sample of 265 patients with first-episode psychosis-five-year follow-up of the Danish OPUS trial. Schizophr Res 107:173\u2013178","journal-title":"Schizophr Res"},{"key":"9161_CR25","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2174\/138161209788957465","volume":"15","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Crippa JA, Martin-Santos R, Winton-Brown T, Fusar-Poli P (2009) Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des 15:2603\u20132614","journal-title":"Curr Pharm Des"},{"key":"9161_CR26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1192\/S0007125000297663","volume":"172","author":"M Birchwood","year":"1998","unstructured":"Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Brit J Psychiatr [Suppl.] 172:53\u201359","journal-title":"Brit J Psychiatr [Suppl.]"},{"key":"9161_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-0327(97)00144-4","volume":"48","author":"S Bonaccorso","year":"1998","unstructured":"Bonaccorso S, Lin AH, Verkerk R, Van Hunsel F, Libbrecht I, Scharpe S, DeClerck L, Biondi M, Janca A, Maes M (1998) Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. J Affect Disord 48:75\u201382","journal-title":"J Affect Disord"},{"key":"9161_CR28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2009.05.014","volume":"121","author":"CM Bonnin","year":"2010","unstructured":"Bonnin CM, Martinez-Aran A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E (2010) Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term follow-up study. J Affect Disord 121:156\u2013160","journal-title":"J Affect Disord"},{"key":"9161_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addbeh.2006.03.018","volume":"32","author":"M Bonn-Miller","year":"2007","unstructured":"Bonn-Miller M, Zvolensky M, Bernstein A (2007) Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers. Addict Behav 32:49\u201362","journal-title":"Addict Behav"},{"key":"9161_CR30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.biopsych.2006.08.009","volume":"61","author":"SJ Borgwardt","year":"2007","unstructured":"Borgwardt SJ, Riecher-R\u00f6ssler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pfl\u00fcger M, Rechsteiner E, D\u2019Souza M, Stieglitz RD, Rad\u00fc EW, McGuire PK (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatr 61:1148\u20131156","journal-title":"Biol Psychiatr"},{"key":"9161_CR31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2008.08.007","volume":"106","author":"SJ Borgwardt","year":"2008","unstructured":"Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pfl\u00fcger M, Stieglitz RD, Rad\u00fc EW, Riecher-R\u00f6ssler A (2008) Reductions in frontal lobe and parietal volume associated with the onset of psychosis. Schizophr Res 106:108\u2013114","journal-title":"Schizophr Res"},{"key":"9161_CR32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S0033291709990341","volume":"40","author":"P Bosanac","year":"2010","unstructured":"Bosanac P, Patton GC, Castle DJ (2010) Early intervention in psychotic disorders: faith before facts? Psychol Med 40:353\u2013358","journal-title":"Psychol Med"},{"key":"9161_CR33","doi-asserted-by":"crossref","unstructured":"Boter H, Derks EM, Fleischhacker WW, Davidson M, Kahn RS, for the EUFEST Study Group (2010) Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST). J Clin Psychiatry 71:58\u201365","DOI":"10.4088\/JCP.08m04506yel"},{"key":"9161_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2009.09.019","volume":"115","author":"H Boter","year":"2009","unstructured":"Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS, EUFEST study group (2009) Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophr Res 115:97\u2013103","journal-title":"Schizophr Res"},{"key":"9161_CR35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","volume":"555","author":"D Braida","year":"2007","unstructured":"Braida D, Liminta V, Malabarba L, Zani A, Sala M (2007) 5-HT(1A) receptors are involved in the anxiolytic effect of delta(9)-tetrahydrocannabinol and AM404, the anandamide transport inhibitor, in Sprague\u2013Dawley rats. Eur J Pharmacol 555:156\u2013163","journal-title":"Eur J Pharmacol"},{"key":"9161_CR36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.162.1.71","volume":"162","author":"WJ Brewer","year":"2005","unstructured":"Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, Yung AR, Anderson VA, McGorry (2005) Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatr 162:71\u201378","journal-title":"Am J Psychiatr"},{"key":"9161_CR37","doi-asserted-by":"crossref","unstructured":"Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, Bramon E, Valmaggia L, Williams SC, Brammer MJ, Chitnis X, McGuire PK (2010) Neural correlates of movement generation in the \u2018at-risk mental state\u2019. Acta Psychiatr Scand. PMID:20064129","DOI":"10.1111\/j.1600-0447.2009.01524.x"},{"key":"9161_CR38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(95)92757-3","volume":"346","author":"PW Burnet","year":"1995","unstructured":"Burnet PW, Harrison PJ (1995) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 346:909","journal-title":"Lancet"},{"key":"9161_CR39","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","volume":"315","author":"ES Burstein","year":"2005","unstructured":"Burstein ES, Ma J, Wong S, Gao Y, Pham E, Knapp AE, Nash NR, Olsson R, Davis RE, Hacksell U, Weiner DM, Brann MR (2005) Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist. J Pharmacol Exp Ther 315:1278\u20131287","journal-title":"J Pharmacol Exp Ther"},{"key":"9161_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","volume":"65","author":"TD Cannon","year":"2008","unstructured":"Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiat 65:28\u201337","journal-title":"Arch Gen Psychiat"},{"key":"9161_CR41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.biopsych.2008.05.019","volume":"64","author":"L Capuron","year":"2009","unstructured":"Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV, Vaccarino V (2009) Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry 64:896\u2013900","journal-title":"Biol Psychiatry"},{"key":"9161_CR42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0447.1999.tb10830.x","volume":"100","author":"S Carbone","year":"1999","unstructured":"Carbone S, Harrigan S, McGorry PD, Curry C, Elkins K (1999) Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand 100:96\u2013104","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2008.100","volume":"19","author":"GA Carlson","year":"2009","unstructured":"Carlson GA, Findling RL, Post RM, Birmaher B, Blumberg HP, Correll C, DelBello MP, Fristad M, Frazier J, Hammen C, Hinshaw SP, Kowatch R, Leibenluft E, Meyer SE, Pavuluri MN, Wagner KD, Tohen M (2009) AACAP 2006 Research Forum-Advancing research in early-onset bipolar disorder: barriers and suggestions. J Child Adolesc Psychopharmacol 19:3\u201312","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"9161_CR44","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1017\/S0033291709990286","volume":"39","author":"WT Carpenter","year":"2009","unstructured":"Carpenter WT, Bustillo JR, Thaker GK, van Os J, Krueger RF, Green MJ (2009) The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med 39:2025\u20132042","journal-title":"Psychol Med"},{"key":"9161_CR45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1176\/jnp.2.2.202","volume":"2","author":"G Cassens","year":"1990","unstructured":"Cassens G, Wolfe L, Zola M (1990) Neuropsychology of depression. J Neuropsychiatry Clin Neurosci 2:202\u2013213","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/WNN.0b013e3181b7ef84","volume":"22","author":"RC Chan","year":"2009","unstructured":"Chan RC, Wang Y, Cheung EF, Cui J, Deng Y, Yuan Y, Ma Z, Yu X, Li Z, Gong Q (2009) Sustained attention deficit along the psychosis proneness continuum: a study on the Sustained Attention to Response Task (SART). Cogn Behav Neurol 22:180\u2013185","journal-title":"Cogn Behav Neurol"},{"key":"9161_CR47","doi-asserted-by":"crossref","unstructured":"Chase TN (2010) Apathy in neuropsychiatric disease: diagnosis, pathophysiology and treatment. Neurotoxicity Res","DOI":"10.1007\/978-1-4614-0785-0_5"},{"key":"9161_CR48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00213-009-1538-z","volume":"205","author":"SF Chen","year":"2009","unstructured":"Chen SF, Shen YC, Chen CH (2009a) HTR2A A-1438G\/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients. Psychopharmacology 205:285\u2013292","journal-title":"Psychopharmacology"},{"key":"9161_CR49","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pnpbp.2009.01.007","volume":"33","author":"SF Chen","year":"2009","unstructured":"Chen SF, Shen YC, Chen CH (2009b) Effects of the DRD3 ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors. Prog Neuropsychopharmacol Biol Psychiatr 33:470\u2013474","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"9161_CR50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1176\/appi.neuropsych.19.1.57","volume":"19","author":"DE Clarke","year":"2007","unstructured":"Clarke DE, Reekum R, Simard M, Streiner DL, Freedman M, Conn D (2007) Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 19:57\u201364","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1092852900020393","volume":"14","author":"M Clerici","year":"2009","unstructured":"Clerici M, Arosio B, Mundo E, Cattaneo E, Pozzoli S, Dell\u2019osso B, Vergani C, Trabattoni D, Altamura AC (2009) Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr 14:419\u2013425","journal-title":"CNS Spectr"},{"key":"9161_CR52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000218518","volume":"42","author":"F Colom","year":"2009","unstructured":"Colom F, Vieta E (2009) The road to DSM-V: bipolar disorder episode and course specifiers. Psychopathology 42:209\u2013218","journal-title":"Psychopathology"},{"key":"9161_CR53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1192\/bjp.bp.107.040485","volume":"194","author":"F Colom","year":"2009","unstructured":"Colom F, Vieta E, S\u00e1nchez-Moreno J, Palomino-Otiniano R, Reinares M, Goikolea JM, Benabarre A, Mart\u00ednez-Ar\u00e1n A (2009) Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 194:260\u2013265","journal-title":"Br J Psychiatry"},{"key":"9161_CR54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2004.01.005","volume":"71","author":"MT Compton","year":"2004","unstructured":"Compton MT, Furman AC, Kaslow NJ (2004) Lower negative symptom scores among cannabis-dependent patients with schizophrenia spectrum disorders: preliminary evidence from an African-American first-episode sample. Schizophr Res 71:61\u201364","journal-title":"Schizophr Res"},{"key":"9161_CR55","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2009.09030311","volume":"166","author":"MT Compton","year":"2009","unstructured":"Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF (2009) Association of pre-onset cannabis, alcohol, and tobacco use with at onset of prodromal and age at onset of psychosis in first-episode patients. Am J Psychiatr 166:1251\u20131257","journal-title":"Am J Psychiatr"},{"key":"9161_CR56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/j.1440-1614.2006.01775.x","volume":"40","author":"P Conus","year":"2006","unstructured":"Conus P, Berk M, McGorry PD (2006) Pharmacological treatment in the early phase of bipolar disorders: what stage are we at? Aust NZ J Psychiatr 40:199\u2013207","journal-title":"Aust NZ J Psychiatr"},{"key":"9161_CR57","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4088\/JCP.v67n1004","volume":"67","author":"B Crespo-Facorro","year":"2006","unstructured":"Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla M, Martinez-Garcia O, Llorca J, Vazquez-Barquero JL (2006) A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatr 67:1511\u20131521","journal-title":"J Clin Psychiatr"},{"key":"9161_CR58","doi-asserted-by":"crossref","unstructured":"Crespo-Facorro B, Arranz MJ, Mata I, Vazquez-Bourgon J, Perez-Iglesias R, Medina-Gonzalez L, Pelayo-Teran JM, Carrasco-Marin E, Vazquez-Barquero JL (2010, in press) 5-HT2A polymorphisms and negative symptoms response to antipsychotic treatment: evidence of association in first episode psychosis patients. Neurotoxicity Res","DOI":"10.1007\/978-1-4614-0785-0_9"},{"key":"9161_CR59","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","volume":"24","author":"JA Crippa","year":"2009","unstructured":"Crippa JA, Zuardi AW, Martin-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P (2009) Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol 24:515\u2013523","journal-title":"Hum Psychopharmacol"},{"key":"9161_CR60","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1002\/hbm.20834","volume":"30","author":"NA Crossley","year":"2009","unstructured":"Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, Bramon E, Valmaggia L, Williams SCR, McGuire PK (2009) Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and first-episode psychosis. Hum Brain Mapp 30:4129\u20134137","journal-title":"Hum Brain Mapp"},{"key":"9161_CR61","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1037\/0003-066X.55.10.1163","volume":"55","author":"M Csikszentmihalyi","year":"2000","unstructured":"Csikszentmihalyi M (2000) Happiness, flow, and economic equality. Am Psychol 55:1163\u20131164","journal-title":"Am Psychol"},{"key":"9161_CR62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1034\/j.1600-0447.2002.02376.x","volume":"106","author":"J Cullberg","year":"2002","unstructured":"Cullberg J, Levander S, Holmqvist R, Mattsson M, Weiselgren IM (2002) One-year outcome in first episode psychosis patients in the Swedish Parachute project. Acta Psychiatr Scand 106:276\u2013285","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","volume":"398","author":"AB Cunha","year":"2006","unstructured":"Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncales CA, Santin A, Kapczinski F (2006) Serum brain derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398:215\u2013219","journal-title":"Neurosci Lett"},{"key":"9161_CR64","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00406-007-0797-0","volume":"258","author":"AB Cunha","year":"2008","unstructured":"Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Goncales CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatr Clin Neurosci 258:300\u2013304","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"9161_CR65","first-page":"58","volume":"12","author":"KR Daffner","year":"1999","unstructured":"Daffner KR, Mesulam MM, Cohen LG (1999) Mechanisms underlying diminished novelty-seeking behavior in patients with probable Alzheimer\u2019s disease. Neurocase 12:58\u201366","journal-title":"Neurocase"},{"key":"9161_CR66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.560","volume":"19","author":"P Dannon","year":"2004","unstructured":"Dannon P, Lowengrub K, Amiaz R, Grunhaus l, Kotler M (2004) Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol 19:97\u2013101","journal-title":"Hum Psychopharmacol"},{"key":"9161_CR67","first-page":"9","volume":"47","author":"IR Dinu","year":"2009","unstructured":"Dinu IR, Popa S, B\u00eecu M, Mo\u0163a E, Mo\u0163a M (2009) The implication of CNR1 gene\u2019s polymorphisms in the modulation of endocannabinoid system effects. Rom J Intern Med 47:9\u201318","journal-title":"Rom J Intern Med"},{"key":"9161_CR68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000228840","volume":"28","author":"RL Drijgers","year":"2009","unstructured":"Drijgers RL, Aalten P, Winogrodzzka A, Verhey FR, Leentjens AF (2009) Pharmacological treatment of apathy in neurodegenerative diseases: a systematic review. Dement Geriatr Cogn Disorder 28:13\u201322","journal-title":"Dement Geriatr Cogn Disorder"},{"key":"9161_CR69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2009.05.022","volume":"121","author":"A Duffy","year":"2010","unstructured":"Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121:127\u2013135","journal-title":"J Affect Disord"},{"key":"9161_CR70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S0033291700038629","volume":"22","author":"PR Dunbar","year":"1992","unstructured":"Dunbar PR, Hill J, Neale TJ, Mellsop GW (1992) Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med 22:1051\u20131057","journal-title":"Psychol Med"},{"key":"9161_CR71","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.300.6719.239","volume":"300","author":"JM Eagles","year":"1990","unstructured":"Eagles JM, Beattie JAG, Restall DB, Rawlinson F, Hagen S, Ashcroft GW (1990) Relation between cognitive impairment and early death in the elderly. Br Mad J 300:239\u2013241","journal-title":"Br Mad J"},{"key":"9161_CR72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2007.03.013","volume":"93","author":"AD Eastvold","year":"2007","unstructured":"Eastvold AD, Heaton RK, Cadenhead KS (2007) Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res 93:266\u2013277","journal-title":"Schizophr Res"},{"key":"9161_CR73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jad.2007.07.001","volume":"106","author":"J Edvardsen","year":"2008","unstructured":"Edvardsen J, Torgersen S, Roysamb E, Lygren S, Skre I, Onstad S, Oien PA (2008) Heritability of bipolar spectrum disorders: unity or heritability? J Affect Disord 106:229\u2013240","journal-title":"J Affect Disord"},{"key":"9161_CR74","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0447.2005.00599.x","volume":"112","author":"J Egeland","year":"2005","unstructured":"Egeland J, Lund A, Landr\u00f6 NI, Rund BR, Sundet K, Asbj\u00f8rnsen A, Mjellem N, Roness A, Stordal KI (2005) Cortisol level predicts executive and memory function in depression, symptom level predicts psychmotor speed. Acta Psychiatr Scand 112:434\u2013441","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cercor\/bhj136","volume":"17","author":"SM Eggan","year":"2007","unstructured":"Eggan SM, Lewis DA (2007) Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cort 17:175\u2013191","journal-title":"Cereb Cort"},{"key":"9161_CR76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eurpsy.2007.09.002","volume":"23","author":"A Faerden","year":"2008","unstructured":"Faerden A, Nesv\u00e5g R, Barrett EA, Agartz I, Finset A, Friis S, Rossberg JI, Melle I (2008) Assessing apathy: the use of the Apathy Evaluation Scale in first episode psychosis. Eur Psychiatr 23:33\u201339","journal-title":"Eur Psychiatr"},{"key":"9161_CR77","doi-asserted-by":"crossref","unstructured":"Frommann I, Pukrop R, Brinkmeyer J, Bechdolf A, Ruhrmann S, Berning J, Decker P, M\u00f6ller HJ, W\u00f6lwer W, Gaebel W, Klosterk\u00f6tter J, Maier W, Wagner M (2010) Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early\u2014and additional memory dysfunction in the late\u2014prodromal state","DOI":"10.1093\/schbul\/sbp155"},{"key":"9161_CR78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","volume":"166","author":"MA Frye","year":"2009","unstructured":"Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T (2009) Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatr 166:164\u2013172","journal-title":"Am J Psychiatr"},{"key":"9161_CR79","doi-asserted-by":"crossref","unstructured":"Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P, on behalf of the OASIS Team (2009b) Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. J Psychiatr Res. PMID:19836755","DOI":"10.1016\/j.jpsychires.2009.08.016"},{"key":"9161_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32831db2d7","volume":"24","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Allen P, Bhattacharyya S, Crippa JA, Mechelli A, Borgwardt S, Martin-Santos R, Seal ML, O\u2019Carrol C, Atakan Z, Zuardi AW, McGuire P (2009) Modulation of effective connectivity during emotional processing by \u03949-tetrahydrocannabinol and cannabinol. Int J Neuropsychopharmacol 24:1\u201312","journal-title":"Int J Neuropsychopharmacol"},{"key":"9161_CR81","doi-asserted-by":"crossref","unstructured":"Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Montgomery AJ, Grasby PM, McGuire PK (2009a) Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatr. PMID:19949389","DOI":"10.1038\/mp.2009.108"},{"key":"9161_CR82","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2009.09.022","volume":"115","author":"S Galderisi","year":"2009","unstructured":"Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, L\u00f3pez-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW, EUFEST group (2009) Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res 115:104\u2013114","journal-title":"Schizophr Res"},{"key":"9161_CR83","volume-title":"Good work: when excellence and ethics meet","author":"H Gardner","year":"2002","unstructured":"Gardner H, Csikszentmihalyi M, Damon W (2002) Good work: when excellence and ethics meet. Basic Books, New York"},{"key":"9161_CR84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J069v25n04_07","volume":"25","author":"D Gilder","year":"2006","unstructured":"Gilder D, Lau P, Dixon M, Corey L, Phillips E, Ehlers C (2006) Comorbidity of select anxiety, affective, and psychotic disorders with cannabis dependence in southwest california indians. J Addict Dis 25:67\u201379","journal-title":"J Addict Dis"},{"key":"9161_CR300","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","volume":"158","author":"M Gitlin","year":"2001","unstructured":"Gitlin M, Nuechterlein K, Subotnik KL, Ventura J, Mintz J, Fogelson DL, Bartzokis G, Aravagiri M (2001) Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatr 158:1835\u20131842","journal-title":"Am J Psychiatr"},{"key":"9161_CR85","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/NMD.0b013e3181b975e6","volume":"197","author":"SM Goulding","year":"2009","unstructured":"Goulding SM, McClure-Tone E, Compton MT (2009) Associations between multiple dimensions of schizotypy and sociodemographic variables in a nonpsychiatric sample of young adults. J Nerv Ment Dis 197:786\u2013789","journal-title":"J Nerv Ment Dis"},{"key":"9161_CR86","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.187.4.306","volume":"187","author":"B Green","year":"2005","unstructured":"Green B, Young R, Kavanagh D (2005) Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatr 187:306\u2013313","journal-title":"Br J Psychiatr"},{"issue":"Suppl. 407","key":"9161_CR87","doi-asserted-by":"crossref","first-page":"s44","DOI":"10.1034\/j.1600-0447.2000.00008.x","volume":"102","author":"H H\u00e4fner","year":"2000","unstructured":"H\u00e4fner H (2000) Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand 102(Suppl. 407):s44\u2013s48","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1192\/bjp.162.1.80","volume":"162","author":"H H\u00e4fner","year":"1993","unstructured":"H\u00e4fner H, Maurer K, L\u00f6ffler W, Riecher-R\u00f6ssler A (1993) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiat 162:80\u201386","journal-title":"Br J Psychiat"},{"key":"9161_CR89","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.schbul.a007008","volume":"29","author":"H H\u00e4fner","year":"2003","unstructured":"H\u00e4fner H, Maurer K, L\u00f6ffler W, an der Heiden W, Hambrecht M, Schultze-Lutter F (2003) Modelling the early course of schizophrenia. Schizophr Bull 29:325\u2013340","journal-title":"Schizophr Bull"},{"key":"9161_CR90","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/j.1440-1614.2000.00736.x","volume":"34","author":"M Hambrecht","year":"2000","unstructured":"Hambrecht M, H\u00e4fner H (2000) Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Austr NZ J Psychiatr 34:468\u2013475","journal-title":"Austr NZ J Psychiatr"},{"key":"9161_CR91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S003329170200675X","volume":"33","author":"SM Harrigan","year":"2003","unstructured":"Harrigan SM, McGorry PD, Krstev H (2003) Does treatment delay in first-episode psychosis really matter? Psychol Med 33:97\u2013110","journal-title":"Psychol Med"},{"key":"9161_CR92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0033291707000797","volume":"38","author":"I Harrison","year":"2008","unstructured":"Harrison I, Joyce EM, Mutsatsa MH, Hutton SB, Huddy V, Kapasi M, Barnes TR (2008) Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study. Psychol Med 38:79\u201388","journal-title":"Psychol Med"},{"key":"9161_CR93","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1124\/mol.66.5.1293","volume":"66","author":"LA Hazelwood","year":"2004","unstructured":"Hazelwood LA, Sanders-Bush E (2004) His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation. Mol Pharmacol 66:1293\u20131300","journal-title":"Mol Pharmacol"},{"key":"9161_CR299","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006842-199307000-00004","volume":"55","author":"TB Herbert","year":"1993","unstructured":"Herbert TB, Cohen S (1993) Stress and immunity in humans. Psychosom Med 55:364\u2013379","journal-title":"Psychosom Med"},{"key":"9161_CR94","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000140085","volume":"77","author":"SE Hetrick","year":"2008","unstructured":"Hetrick SE, Parker AG, Hickie IB, Purcell R, Yung AR, McGorry PD (2008a) Early identification and intervention in depressive disorders: towards a clinical staging model. Psychother Psychosom 77:263\u2013270","journal-title":"Psychother Psychosom"},{"key":"9161_CR95","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/10398560802189888","volume":"16","author":"SE Hetrick","year":"2008","unstructured":"Hetrick SE, Simmons M, Merry S (2008b) SSRIs and depression in children and adolescents: the imperative for shared decision-making. Australia Psychiatr 16:354\u2013358","journal-title":"Australia Psychiatr"},{"key":"9161_CR96","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.38377.715799.F7","volume":"330","author":"S Hollinghurst","year":"2005","unstructured":"Hollinghurst S, Kessler D, Peters TJ, Gunnell D (2005) Opportunity cost of antidepressant prescribing in England: analysis of routine data. BMJ 330:999\u20131000","journal-title":"BMJ"},{"key":"9161_CR97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","volume":"66","author":"OD Howes","year":"2009","unstructured":"Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatr 66:13\u201320","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR98","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF01233097","volume":"16","author":"CL Hsieh","year":"1990","unstructured":"Hsieh CL, Bowcock AM, Farrer LA, Hebert JM, Huang KN, Cavalli-Sforza LL, Julius D, Francke U (1990) The serotonin subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14. Somat Cell Mol Genet 16:567\u2013574","journal-title":"Somat Cell Mol Genet"},{"key":"9161_CR99","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2009.06.103","volume":"1293","author":"JG Hunsberger","year":"2009","unstructured":"Hunsberger JG, Austin DR, Chen G, Manji HK (2009) Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity. Brain Res 1293:76\u201384","journal-title":"Brain Res"},{"key":"9161_CR100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2008.540","volume":"66","author":"TR Insel","year":"2009","unstructured":"Insel TR (2009) Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiat 66:128\u2013133","journal-title":"Arch Gen Psychiat"},{"key":"9161_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-585-37970-8_1","volume":"461","author":"M Irwin","year":"1999","unstructured":"Irwin M (1999) Immune correlates of depression. Adv Exp Med Biol 461:1\u201324","journal-title":"Adv Exp Med Biol"},{"key":"9161_CR102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0165-0327(98)00083-4","volume":"53","author":"G Isacsson","year":"1999","unstructured":"Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U (1999) Selective serotonin reuptake inhibitors have broadened the utilization of antidepressant treatment in accordance with recommendations: findings from a Swedish database. Affect Disord 53:15\u201322","journal-title":"Affect Disord"},{"key":"9161_CR103","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/mds.10041","volume":"17","author":"V Isella","year":"2002","unstructured":"Isella V, Melzi P, Grimaldi M, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I (2002) Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson\u2019s disease. Mov Disord 17:366\u2013371","journal-title":"Mov Disord"},{"key":"9161_CR104","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/jnnp.74.9.1308","volume":"74","author":"V Isella","year":"2003","unstructured":"Isella V, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I (2003) Physical anhedonia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatr 74:1308\u20131311","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9161_CR105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1099-1166(199701)12:1<53::AID-GPS507>3.0.CO;2-M","volume":"12","author":"B Johansson","year":"1997","unstructured":"Johansson B, Zarit SH (1997) Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Ger Psychiatr 12:53\u201359","journal-title":"Int J Ger Psychiatr"},{"key":"9161_CR106","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","volume":"371","author":"RS Kahn","year":"2008","unstructured":"Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, L\u00f3pez-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-R\u00f6ssler A, Grobbee DE, the EUFEST study group (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371:1085\u20131097","journal-title":"Lancet"},{"key":"9161_CR107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/S1516-44462008000300011","volume":"30","author":"F Kapczinski","year":"2008","unstructured":"Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant\u2019Anna M, Cunha AB, Post RM (2008a) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30:243\u2013245","journal-title":"Rev Bras Psiquiatr"},{"key":"9161_CR108","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","volume":"32","author":"F Kapczinski","year":"2008","unstructured":"Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant\u2019anna M, Grassi-Oliveira R, Post RM (2008b) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675\u2013692","journal-title":"Neurosci Biobehav Rev"},{"key":"9161_CR109","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/ern.09.31","volume":"9","author":"F Kapczinski","year":"2009","unstructured":"Kapczinski F, Dias VV, Kauer-Sant\u2019Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:957\u2013966","journal-title":"Expert Rev Neurother"},{"key":"9161_CR110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","volume":"6","author":"S Kasper","year":"2003","unstructured":"Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, Archibald D, Ingenito G, Marcus R, Pigott T (2003) Efficacy and safety of aripipazole vs. haloperidol for long-term maintainence treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol 6:325\u2013337","journal-title":"Int J Neuropsychopharmacol"},{"key":"9161_CR111","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","volume":"74","author":"JP Kelly","year":"1997","unstructured":"Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299\u2013316","journal-title":"Pharmacol Ther"},{"key":"9161_CR112","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11920-007-0040-8","volume":"9","author":"MS Keshaven","year":"2007","unstructured":"Keshaven MS, Amirsadri A (2007) Early intervention in schizophrenia: current and future perspectives. Curr Psychiat Rep 9:325\u2013328","journal-title":"Curr Psychiat Rep"},{"key":"9161_CR113","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1600-0447.2003.00266.x","volume":"109","author":"LV Kessing","year":"2004","unstructured":"Kessing LV, Hansen MG, Andersen PK, Angst (2004) The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders\u2014a life-long perspective. Acta Psychiatr Scand 109:339\u2013344","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.v67n0113","volume":"67","author":"TA Ketter","year":"2006","unstructured":"Ketter TA, Houston JP, Adams DH, Risser RC, Al Meyers, Williamson DK, Tohen M (2006) Differential efficacy of olanzepine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatr 67:95\u2013101","journal-title":"J Clin Psychiatr"},{"key":"9161_CR115","unstructured":"Killackey E, McGorry PD (2009) Interventions in the early stages of psychosis. Psychiatr Ann (in press). PMID:18836852"},{"key":"9161_CR116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hup.897","volume":"23","author":"B Kim","year":"2008","unstructured":"Kim B, Choi EY, Kim CY, Song K, Joo YH (2008) Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting. Hum Psychopharmacol 23:61\u201367","journal-title":"Hum Psychopharmacol"},{"key":"9161_CR117","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00019442-200108000-00011","volume":"9","author":"DN Kiosses","year":"2001","unstructured":"Kiosses DN, Klimstra S, Murphy C, Alexopoulos GS (2001) Executive dysfunction and disability in elderly patients with major depression. Am J Geriatr Psychiatr 9:269\u2013274","journal-title":"Am J Geriatr Psychiatr"},{"key":"9161_CR118","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/01.wnl.0000230572.07791.22","volume":"67","author":"L Kirsch-Darrow","year":"2006","unstructured":"Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D (2006) Dissociating apathy and depression in Parkinson\u2019s disease. Neurology 67:33\u201338","journal-title":"Neurology"},{"key":"9161_CR119","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archpsyc.58.2.158","volume":"58","author":"J Klosterk\u00f6tter","year":"2001","unstructured":"Klosterk\u00f6tter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatr 58:158\u2013164","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR120","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.52.7.1403","volume":"52","author":"G Kuzis","year":"1999","unstructured":"Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein SE (1999) Neuropsychological correlates of apathy and depression in patients with dementia. Neurology 52:1403\u20131407","journal-title":"Neurology"},{"key":"9161_CR121","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1176\/appi.ajp.159.9.1593","volume":"159","author":"HY Lane","year":"2002","unstructured":"Lane HY, Chang YC, Chiu CC, Chen ML, Hsieh MH, Chang WH (2002) Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatr 159:1593\u20131595","journal-title":"Am J Psychiatr"},{"key":"9161_CR122","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/gps.1642","volume":"21","author":"L Larraga","year":"2006","unstructured":"Larraga L, Saz P, Dewey ME, Marcos G, Lobo A, ZARADEMP Workgroup (2006) Validation of the Spanish version of the EURO-D scale: an instrument for detecting depression in older people. Int J Geriatr Psychiatry 21:1199\u20131205","journal-title":"Int J Geriatr Psychiatry"},{"key":"9161_CR123","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1176\/appi.ajp.158.11.1917","volume":"158","author":"TK Larsen","year":"2001","unstructured":"Larsen TK, McGlashan TH, Johannessen JO, Friis S, Guldberg C, Haahr U, Horneland M, Melle I, Moe LC, Opjordsmoen S, Simonsen E, Vaglum P (2001) Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatr 158:1917\u20131919","journal-title":"Am J Psychiatr"},{"key":"9161_CR124","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/sleep\/32.8.1027","volume":"32","author":"M LeBlanc","year":"2009","unstructured":"LeBlanc M, M\u00e9rette C, Savard J, Ivers H, Baillargeon L, Morin CM (2009) Incidence and risk factors of insomnia in a population-based sample. Sleep 32:1027\u20131037","journal-title":"Sleep"},{"key":"9161_CR125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/gps.2125","volume":"24","author":"L Lechowski","year":"2009","unstructured":"Lechowski L, Benoit M, Chassagne P, Vedel I, Tortrat D, Teillet L, Vellas B (2009) Persistent apathy in Alzheimer\u2019s disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study. Int J Geriatr Psychiatr 24:341\u2013346","journal-title":"Int J Geriatr Psychiatr"},{"key":"9161_CR126","first-page":"1004","volume":"23","author":"AFG Leentjens","year":"2008","unstructured":"Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Apathy and Anhedonia Rating Scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 23:1004\u20132014","journal-title":"Mov Disord"},{"key":"9161_CR127","first-page":"886","volume":"61","author":"AFG Leentjens","year":"2009","unstructured":"Leentjens AFG, Koester J, Fruh B, Shepard DT, Barone P, Houben JJ (2009) The effect of pramipexole on mood and motivation symptoms in Parkinson\u2019s disease: a meta-analysis of placebo-controlled studies. Clin Ther 61:886\u2013895","journal-title":"Clin Ther"},{"key":"9161_CR128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/appi.neuropsych.17.2.214","volume":"17","author":"MR Lemke","year":"2005","unstructured":"Lemke MR, Brecht HM, Koester J, Kraus PH, Reichmann H (2005) Anhedonia, depression, and motor functioning in Parkinson\u2019s diseaseduring treatment with pramipexole. J Neuropsychiatry Clin Neurosci 17:214\u2013220","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jns.2006.05.024","volume":"248","author":"MR Lemke","year":"2006","unstructured":"Lemke MR, Brecht HM, Kraus PH, Reichmann H (2006) Effects of the dopamine agonist pramipexole on depression, anhedonis and motor functioning in Parkinson\u2019s disease. J Neurol Sci 248:266\u2013270","journal-title":"J Neurol Sci"},{"key":"9161_CR130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.neuropsych.21.3.271","volume":"21","author":"EJ Lenze","year":"2009","unstructured":"Lenze EJ, Munin MC, Dew MA, Marin RS, Butters MA, Skidmore ER, Whyte EM, Begley A, Reynolds CF (2009) Apathy after hip fracture: a potential target for intervention to improve functional outcomes. J Neuropsychiatry Clin Neurosci 21:271\u2013278","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2006.11.023","volume":"101","author":"E Levander","year":"2007","unstructured":"Levander E, Frye MA, McElroy S, Suppes T, Grunze H, Nolen WA, Kupka R, Keck PE Jr, Leverich GS, Altshuler LL, Hwang S, Mintz J, Post RM (2007) Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. J Affect Disord 101:211\u2013217","journal-title":"J Affect Disord"},{"key":"9161_CR132","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpeds.2006.10.070","volume":"150","author":"GS Leverich","year":"2007","unstructured":"Leverich GS, Post RM, Keck PE Jr, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D (2007) The poor prognosis of childhood-onset bipolar disorder. J Pediatr 150:485\u2013490","journal-title":"J Pediatr"},{"key":"9161_CR133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00001756-199901180-00011","volume":"10","author":"CH Lin","year":"1999","unstructured":"Lin CH, Tsai SJ, Yu YW, Song HL, Tu PC, Sim CB, Hsu CP, Yang KH, Hong CJ (1999) No evidence for association of serotonin-2A receptor variant (102T\/C) with schizophrenia or clozapine response in a Chinese population. NeuroReport 10:57\u201360","journal-title":"NeuroReport"},{"key":"9161_CR134","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DH Linszen","year":"1994","unstructured":"Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis use and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatr 51:273\u2013279","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR135","first-page":"167","volume":"80","author":"A Little","year":"2009","unstructured":"Little A (2009) Treatment-resistant depression. Am Fam Physician 80:167\u2013172","journal-title":"Am Fam Physician"},{"key":"9161_CR136","doi-asserted-by":"crossref","unstructured":"Lobo A, Lopez-Anton R, De-La-Camara C, Quintanilla MA, Campayo A, Santabarbara J, Martin A, Saz P, Marcos G, the ZARADEMP Workgroup (2010) Staging of cognitive impairment, incidence of dementia and mortality risk: a simple method based on the Mini Mental Status Examination. Neurotoxicity Res (in press)","DOI":"10.1007\/978-1-4614-0785-0_10"},{"key":"9161_CR137","first-page":"40","volume":"19","author":"A Lobo","year":"2005","unstructured":"Lobo A, Saz P, Marcos G et al (2005) The ZARADEMP-project on the incidence, prevalence and risk factors of dementia (and depression) in the elderly community: II. Methods and first results. Eur J Psychiatr 19:40\u201354","journal-title":"Eur J Psychiatr"},{"key":"9161_CR138","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.2007.01006.x","volume":"116","author":"A Lobo","year":"2007","unstructured":"Lobo A, Saz P, Marcos G, Dia JL, De-la-Camara C, Ventura T, Monta\u00f1es JA, Lobo-Escolar A, Aznar S, ZARADEMP Workgroup (2007) Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project. Acta Psychiatr Scand 116:299\u2013307","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR139","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000147947","volume":"77","author":"A Lobo-Escolar","year":"2008","unstructured":"Lobo-Escolar A, Roy JF, Saz P, De-la-C\u00e1mara C, Marcos G, Lobo A, ZARADEMP Workgroup (2008a) Association of hypertension with depression in community-dwelling elderly persons: results from the ZARADEMP Project. Psychother Psychosom 77:323\u2013325","journal-title":"Psychother Psychosom"},{"key":"9161_CR140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpsychores.2008.03.002","volume":"65","author":"A Lobo-Escolar","year":"2008","unstructured":"Lobo-Escolar A, Saz P, Marcos G, Quintanilla MA, Campayo A, Lobo A, ZARADEMP Workgroup (2008b) Somatic and psychiatric comorbidity in the general elderly population: results from the ZARADEMP Project. J Psychosom Res 65:347\u2013355","journal-title":"J Psychosom Res"},{"key":"9161_CR141","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/JGP.0b013e3180437db3","volume":"15","author":"U Lueken","year":"2007","unstructured":"Lueken U, Seidl U, V\u00f6lker L, Schweiger E, Kruse A, Schr\u00f6der J (2007) Development of a short version of the Apathy Evaluation Scale specifically adapted for dementia nursing home residents. Am J Geriatr Psychiatr 15:376\u2013378","journal-title":"Am J Geriatr Psychiatr"},{"key":"9161_CR142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF03033802","volume":"14","author":"S Luzi","year":"2008","unstructured":"Luzi S, Morrison PD, Powell J, di Forti M, Murray RM (2008) What is the mechanism whereby cannabis use increases risk of psychosis? Neurotox Res 14:105\u2013112","journal-title":"Neurotox Res"},{"key":"9161_CR143","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/070674370404901204","volume":"49","author":"GS Mahli","year":"2004","unstructured":"Mahli GS, Ivanovski B, Szekeres V, Olley A (2004) Bipolar disorder: it\u2019s all in the mind? The neurological profile of a biological disorder. Can J Psychiatr 49:813\u2013819","journal-title":"Can J Psychiatr"},{"key":"9161_CR144","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1176\/ajp.153.8.1092","volume":"153","author":"AK Malhotra","year":"1996","unstructured":"Malhotra AK, Goldman D, Ozaki N, Breier A, Buchanan R, Pickar D (1996) Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatr 153:1092\u20131094","journal-title":"Am J Psychiatr"},{"key":"9161_CR145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/070674379303800910","volume":"38","author":"AK Malla","year":"1993","unstructured":"Malla AK, Norman RM, Williamson P (1993) Stability of positive and negative symptoms in schizophrenia. Can J Psychiatr 38:617\u2013621","journal-title":"Can J Psychiatr"},{"key":"9161_CR146","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4088\/JCP.v63n0503","volume":"63","author":"LB Marangell","year":"2002","unstructured":"Marangell LB, Johnson CR, Kertz B, Zboyan HA, Martinez JM (2002) Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. J Clin Psychiatr 63:391\u2013395","journal-title":"J Clin Psychiatr"},{"key":"9161_CR147","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.147.1.22","volume":"147","author":"RS Marin","year":"1990","unstructured":"Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatr 147:22\u201330","journal-title":"Am J Psychiatr"},{"key":"9161_CR296","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/jnp.3.3.243","volume":"3","author":"RS Marin","year":"1991","unstructured":"Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243\u2013254","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR148","first-page":"205","volume-title":"Review of psychiatry","author":"RS Marin","year":"1996","unstructured":"Marin RS (1996) Apathy and related disorders of diminished motivation. In: Dickstein LJ, Riba MB, Oldham JM (eds) Review of psychiatry, vol 15. American Psychiatric Press, Washington DC, pp 205\u2013242"},{"key":"9161_CR150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00001199-200507000-00009","volume":"20","author":"RS Marin","year":"2005","unstructured":"Marin RS, Wilkosz PA (2005) Disorders of diminished motivation. J Head Trauma Rehabil 20:377\u2013388","journal-title":"J Head Trauma Rehabil"},{"key":"9161_CR151","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Firincigullari S, Biedrzycki RC (1991) Reliability and validity of the Apathy Evaluation Scale. Psychiatr Res 38:143\u2013162","journal-title":"Psychiatr Res"},{"key":"9161_CR152","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0327(93)90040-Q","volume":"28","author":"RS Marin","year":"1993","unstructured":"Marin RS, Biedrzycki RC, Firincigullari S (1993) The sources of convergence between measures of apathy and depression. J Affect Disord 28:117\u2013124","journal-title":"J Affect Disord"},{"key":"9161_CR295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0891988703016002009","volume":"16","author":"RS Marin","year":"2003","unstructured":"Marin RS, Butters MA, Mulsant BH, Pollock BG, Reynolds CF (2003) Apathy and executive function in depressed elderly. J Geriatr Psychiatr Neurol 16:112\u2013118","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"9161_CR153","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.20723","volume":"21","author":"L Marsh","year":"2006","unstructured":"Marsh L, McDonald WM, Cummings J, Ravina B, NINDS\/NIMH Work Group on Depression, Parkinson\u2019s Disease (2006) Provisional diagnostic criteria for depression in Parkinson\u2019s disease: report of an NINDS\/NIMH Work Group. Mov Disord 21:148\u2013158","journal-title":"Mov Disord"},{"key":"9161_CR154","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.62.9.975","volume":"62","author":"M Marshall","year":"2005","unstructured":"Marshall M, Lewis S, Lockwood A et al (2005) Association between duration of untreated psychosis and in cohorts of first-episode outcome patients: a systematic review. Arch Gen Psychiat 62:975\u2013983","journal-title":"Arch Gen Psychiat"},{"key":"9161_CR155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1176\/appi.ajp.161.2.262","volume":"161","author":"A Martinez-Aran","year":"2004","unstructured":"Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, S\u00e1nchez-Moreno J, Benabarre A, Goikolea JM, Comes M, Salamero M (2004) Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatr 161:262\u2013270","journal-title":"Am J Psychiatr"},{"key":"9161_CR156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0893-133X(98)00007-4","volume":"19","author":"M Masellis","year":"1998","unstructured":"Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, Howard A, Badri F, Nothen MM, Kalow W, Kennedy JL (1998) Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenic patients. Neuropsychopharmacology 19:123\u2013132","journal-title":"Neuropsychopharmacology"},{"key":"9161_CR157","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.schres.2004.04.006","volume":"7","author":"O Mason","year":"2004","unstructured":"Mason O, Startup M, Halpin S et al (2004) Risk factors for transition to first episode psychosis among individuals with \u2018at-risk mental states\u2019. Schizophr Res 7:227\u2013237","journal-title":"Schizophr Res"},{"key":"9161_CR158","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","volume":"100","author":"RJ Mathew","year":"1999","unstructured":"Mathew RJ, Wilson WH, Chiu NY, Turkington TG, Degrado TR, Coleman RE (1999) Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand 100:67\u201375","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR159","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(02)00069-0","volume":"116","author":"RJ Mathew","year":"2002","unstructured":"Mathew RJ, Wilson WH, Turkington TG, Hawk TC, Coleman RE, DeGrado TR, Provenzale J (2002) Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatry Res 116:173\u2013185","journal-title":"Psychiatry Res"},{"key":"9161_CR160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/S0007125000297584","volume":"172","author":"TH McGlashan","year":"1998","unstructured":"McGlashan TH (1998) Early detection and intervention of schizophrenia: rationale and research. Br J Psychiat 172:3\u20136","journal-title":"Br J Psychiat"},{"key":"9161_CR161","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1176\/ajp.2007.164.6.859","volume":"164","author":"PD McGorry","year":"2007","unstructured":"McGorry PD (2007) Issues for DSM-V: clinical staging, a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiat 164:859\u2013860","journal-title":"Am J Psychiat"},{"key":"9161_CR162","doi-asserted-by":"crossref","unstructured":"McGorry PD (2010) Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment. Neurotoxicity Res (in press)","DOI":"10.1007\/s12640-010-9179-x"},{"key":"9161_CR163","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1440-1614.2003.01192.x","volume":"37","author":"PD McGorry","year":"2003","unstructured":"McGorry PD, Yung AR (2003) Early intervention in psychosis: an overdue reform. Aust NZ J Psychiat 37:393\u2013398","journal-title":"Aust NZ J Psychiat"},{"key":"9161_CR164","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/schbul\/22.2.305","volume":"22","author":"PD McGorry","year":"1996","unstructured":"McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ (1996) EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 22:305\u2013326","journal-title":"Schizophr Bull"},{"key":"9161_CR165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0920-9964(01)00235-3","volume":"51","author":"PD McGorry","year":"2001","unstructured":"McGorry PD, Yung AR, Phillips L (2001) Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res 51:17\u201329","journal-title":"Schizophr Res"},{"key":"9161_CR166","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/j.1440-1614.2006.01860.x","volume":"40","author":"PD McGorry","year":"2006","unstructured":"McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust NZ J Psychiat 40:616\u2013622","journal-title":"Aust NZ J Psychiat"},{"issue":"Suppl. 7","key":"9161_CR167","first-page":"s5","volume":"187","author":"PD McGorry","year":"2007","unstructured":"McGorry PD, Purcell R, Hickie IB, Jorm AF (2007) Investing in youth mental health is a best buy. Med J Austral 187(Suppl. 7):s5","journal-title":"Med J Austral"},{"key":"9161_CR168","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.2051-5545.2008.tb00182.x","volume":"7","author":"PD McGorry","year":"2008","unstructured":"McGorry PD, Killackey E, Yung AR (2008a) Early intervention in psychosis: concepts, evidence and future directions. World Psychiat 7:148\u2013156","journal-title":"World Psychiat"},{"key":"9161_CR169","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archgenpsychiatry.2007.9","volume":"65","author":"PD McGorry","year":"2008","unstructured":"McGorry PD, Yung AR, Bechdorf A, Amminger P (2008b) Back to the future: predicting and reshaping the course of psychotic disorder. Arch Gen Psychiatr 65:25\u201327","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR170","doi-asserted-by":"crossref","unstructured":"McGorry PD, Johannessen JO, Lewis S, Birchwood M, Malla A, Nordentoft M, Addington A, Yung A (2009a) Early intervention in psychosis: keeping faith with evidence-based health care. Psychol Med. PMID:19886337","DOI":"10.1017\/S0033291709991346"},{"key":"9161_CR171","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4088\/JCP.08r04472","volume":"70","author":"PD McGorry","year":"2009","unstructured":"McGorry PD, Nelson B, Amminger P, Bechdolf A, Francey SM, Berger G, Riecher-R\u00f6ssler A, KlosterK\u00f6tter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, MsGuire P, Berk M, Chen YH, keshaven MS, Yung AR (2009b) Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiat 70:1206\u20131212","journal-title":"J Clin Psychiat"},{"key":"9161_CR172","volume-title":"Staging neuropsychiatric disorders: implications for etiopathogenesis and treatment","author":"PK McGuire","year":"2010","unstructured":"McGuire PK (2010) Brain imaging in early stages of psychosis. In: Palomo T, Beninger RJ, Kostrzewa RM, Archer T (eds) Staging neuropsychiatric disorders: implications for etiopathogenesis and treatment. F.P. Graham Publishing, Mountain Home USA"},{"key":"9161_CR173","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archpsyc.61.2.143","volume":"61","author":"I Melle","year":"2004","unstructured":"Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Ruud BR, Vaglum P, McGlashan T (2004) Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiat 61:143\u2013150","journal-title":"Arch Gen Psychiat"},{"issue":"Suppl. 1","key":"9161_CR174","first-page":"s330","volume":"35","author":"I Melle","year":"2009","unstructured":"Melle I, Larsen TK, Friis S, Vaglum P, Johannessen JO, Simonsen E, Haahr U, Opjordsmoen S, Ruud BR, Rossberg JL, Joa I, hegelstad W, Langeveld H, Evensen J, McGlashan T (2009) Early detection of first psychosis: TIPS sample five year outcomes. Schizophr Bull 35(Suppl. 1):s330","journal-title":"Schizophr Bull"},{"issue":"Suppl 2","key":"9161_CR175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11318630-000000000-00000","volume":"23","author":"J Mendlewicz","year":"2009","unstructured":"Mendlewicz J (2009) Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs 23(Suppl 2):15\u201326","journal-title":"CNS Drugs"},{"key":"9161_CR176","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","volume":"64","author":"KR Merikangas","year":"2007","unstructured":"Merikangas KR, Akiskal HS, Angst J (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatr 64:543\u2013552","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR177","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbr.2008.12.022","volume":"204","author":"U Meyer","year":"2009","unstructured":"Meyer U, Feldon J (2009) Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res 204:322\u2013334","journal-title":"Behav Brain Res"},{"key":"9161_CR178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2009.09.009","volume":"24","author":"AH Miller","year":"2010","unstructured":"Miller AH (2010) Depression and immunity: a role for T cells? Brain Behav Immun 24:1\u20138","journal-title":"Brain Behav Immun"},{"key":"9161_CR179","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","volume":"159","author":"TJ Miller","year":"2002","unstructured":"Miller TJ, McGlashan TH, Rosen JL et al (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiat 159:863\u2013865","journal-title":"Am J Psychiat"},{"key":"9161_CR180","first-page":"1","volume":"17","author":"G Modinos","year":"2009","unstructured":"Modinos G, Mechelli A, Ormel J, Groenewold NA, Aleman A, McGuire PK (2009) Schizotypy and brain structure: a voxel-based morphometry study. Psychol Med 17:1\u20139","journal-title":"Psychol Med"},{"issue":"9584","key":"9161_CR181","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319\u2013328","journal-title":"Lancet"},{"key":"9161_CR182","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pscychresns.2009.04.003","volume":"174","author":"TW Moorhead","year":"2009","unstructured":"Moorhead TW, Stanfield A, Spencer M, Hall J, McIntosh A, Owens DC, Lawrie S, Johnstone E (2009) Progressive temporal lobe grey matter loss in adolescents with schizotypal traits and mild intellectual impairment. Psychiatry Res 174:105\u2013109","journal-title":"Psychiatry Res"},{"key":"9161_CR183","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1369-1600.2008.00104.x","volume":"13","author":"FA Moreira","year":"2008","unstructured":"Moreira FA, Lutz B (2008) The endocannabinoid system: emotion, learning and addiction. Addict Biol 13:196\u2013212","journal-title":"Addict Biol"},{"key":"9161_CR184","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","volume":"39","author":"PD Morrison","year":"2009","unstructured":"Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM (2009) The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med 39:1607\u20131616","journal-title":"Psychol Med"},{"key":"9161_CR185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2009.02.001","volume":"51","author":"G Moukas","year":"2010","unstructured":"Moukas G, Stathopoulou A, Gourzis P, Beratis IN, Beratis S (2010) Relationship of \u201cprodromal\u201d symptoms with severity and type of psychopathology in the active phase of schizophrenia. Compr Psychiatry 51:1\u20137","journal-title":"Compr Psychiatry"},{"key":"9161_CR186","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N M\u00fcller","year":"2007","unstructured":"M\u00fcller N, Schwarz MJ (2007a) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatr 12:988\u20131000","journal-title":"Mol Psychiatr"},{"issue":"258\u2013260","key":"9161_CR187","first-page":"262","volume":"253\u2013256","author":"N M\u00fcller","year":"2007","unstructured":"M\u00fcller N, Schwarz MJ (2007b) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neurotransmiss 78 253\u2013256(258\u2013260):262\u2013263","journal-title":"J Neurotransmiss 78"},{"issue":"Suppl 2","key":"9161_CR188","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00406-008-2012-3","volume":"258","author":"N M\u00fcller","year":"2008","unstructured":"M\u00fcller N, Schwarz MJ (2008a) A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci 258(Suppl 2):97\u2013106","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"9161_CR189","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2174\/138161208784480243","volume":"14","author":"N M\u00fcller","year":"2008","unstructured":"M\u00fcller N, Schwarz MJ (2008b) COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des 14:1452\u20131465","journal-title":"Curr Pharm Des"},{"key":"9161_CR190","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N M\u00fcller","year":"2006","unstructured":"M\u00fcller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-M\u00fcller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, M\u00f6ller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680\u2013684","journal-title":"Mol Psychiatry"},{"key":"9161_CR191","doi-asserted-by":"crossref","first-page":"319","DOI":"10.31887\/DCNS.2009.11.3\/nmueller","volume":"11","author":"N M\u00fcller","year":"2009","unstructured":"M\u00fcller N, Myint AM, Schwarz MJ (2009) The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders\u2014relation to drug treatment. Dialogues Clin Neurosci 11:319\u2013332","journal-title":"Dialogues Clin Neurosci"},{"key":"9161_CR192","doi-asserted-by":"crossref","unstructured":"M\u00fcller N, Myint AM, Schwarz MJ (2010) Inflammatory biomarkers and depression. Neurotoxicity Res (in press)","DOI":"10.1007\/978-1-4614-0785-0_7"},{"key":"9161_CR301","unstructured":"Murray KM (2010) Cannabis and psychosis. In: Palomo T, Beninger RJ, Kostrzewa RM, Archer T (eds) Staging neuropsychiatric disorders: implication for etiopathogenesis and treatment. Graham publ., Mountain View"},{"key":"9161_CR193","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Global mortality, disability, and the contributions of risk factors: global burden of disease study. Lancet 349:1436\u20131442","journal-title":"Lancet"},{"key":"9161_CR194","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrn2253","volume":"8","author":"RM Murray","year":"2007","unstructured":"Murray RM, Morrison PD, Henquet C, Di Forti M (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8:885\u2013895","journal-title":"Nat Rev Neurosci"},{"key":"9161_CR195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000107420","volume":"14","author":"AM Myint","year":"2007","unstructured":"Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE (2007) Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bbulbectomised rat model of depression. Neuroimmunomodulation 14:65\u201371","journal-title":"Neuroimmunomodulation"},{"key":"9161_CR196","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/j.2051-5545.2009.tb00222.x","volume":"8","author":"WE Narrow","year":"2009","unstructured":"Narrow WE, Kuhl EA, Regier DA (2009) DSM-V perspectives on disentangling disability from clinical significance. World Psychiatr 8:88\u201389","journal-title":"World Psychiatr"},{"key":"9161_CR197","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/00048670701827630","volume":"42","author":"B Nelson","year":"2008","unstructured":"Nelson B, Simmons MB, Yung AR, Buckby JA, O\u2019Dwyer L, Francey SM, Leicester S, Bapat S, McGorry PD (2008) Identifying the ultra-high risk (prodromal) population: evaluation of training workshops with mental health services. Aust N Z J Psychiatr 42:236\u2013243","journal-title":"Aust N Z J Psychiatr"},{"key":"9161_CR198","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","volume":"23","author":"FG Nery","year":"2008","unstructured":"Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, Bowden CL, Soares JC (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmarcol 23:87\u201394","journal-title":"Hum Psychopharmarcol"},{"key":"9161_CR199","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(95)92756-5","volume":"346","author":"MM Nothen","year":"1995","unstructured":"Nothen MM, Rietschel M, Erdmann J, Oberlander H, Moller HJ, Nober D, Propping P (1995) Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 346:908\u2013909","journal-title":"Lancet"},{"key":"9161_CR200","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1211\/002235703322277186","volume":"55","author":"G Nowak","year":"2003","unstructured":"Nowak G, Siwek M, Dudek D, Zieba A, Pilc A (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 55:1143\u20131147","journal-title":"Pol J Pharmacol"},{"key":"9161_CR201","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2004.09.035","volume":"372","author":"S Nudmamud-Thanoi","year":"2004","unstructured":"Nudmamud-Thanoi S, Reynolds GP (2004) The NR1 subunit of the glutamate\/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 372:173\u2013177","journal-title":"Neurosci Lett"},{"key":"9161_CR202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1176\/appi.neuropsych.19.1.81","volume":"19","author":"PR Padala","year":"2007","unstructured":"Padala PR, Burke WJ, Bhatia SC, Petty F (2007) Treatment of apathy with methylphenidate. J Neuropsychiatry Clin Neurosci 19:81\u201383","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03033572","volume":"14","author":"T Palomo","year":"2008","unstructured":"Palomo T, Beninger RJ, Kostrzewa RM, Archer T (2008a) Focusing on symptoms rather than diagnosis in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making. Neurotoxicity Res 14:1\u201320","journal-title":"Neurotoxicity Res"},{"key":"9161_CR204","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03033800","volume":"14","author":"T Palomo","year":"2008","unstructured":"Palomo T, Kostrzewa RM, Beninger RJ, Archer T (2008b) Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths. Neurotoxicity Res 14:79\u201396","journal-title":"Neurotoxicity Res"},{"key":"9161_CR205","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1176\/appi.ajp.162.12.2220","volume":"162","author":"DL Penn","year":"2005","unstructured":"Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA (2005) Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatr 162:2220\u20132232","journal-title":"Am J Psychiatr"},{"key":"9161_CR206","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","volume":"162","author":"DO Perkins","year":"2005","unstructured":"Perkins DO, Gu H, Boteva K, Lieberman JA (2005) Relationship between duration of untreated psychosis and in cohorts of first-episode outcome schizophrenia: a critical review and meta-analysis. Am J Psychiat 162:1785\u20131804","journal-title":"Am J Psychiat"},{"key":"9161_CR207","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2007.09.003","volume":"97","author":"MO Pfl\u00fcger","year":"2007","unstructured":"Pfl\u00fcger MO, Gschwander U, Stieglitz RD, Riecher-R\u00f6ssler A (2007) Neuropsychological deficits in individuals with an at risk mental state for psychosis-working memory as a potential trait marker. Schizophr Res 97:14\u201324","journal-title":"Schizophr Res"},{"key":"9161_CR208","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.73.6.636","volume":"73","author":"GC Pluck","year":"2002","unstructured":"Pluck GC, Brown RG (2002) Apathy in Parkinson\u2019 disease. J Neurol Neurosurg Psychiatr 73:636\u2013642","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9161_CR209","doi-asserted-by":"crossref","first-page":"193","DOI":"10.31887\/DCNS.2008.10.2\/rmpost","volume":"10","author":"RM Post","year":"2008","unstructured":"Post RM (2008) Promising avenues of therapeutics for bipolar illness. Dialogues Clin Neurosci 10:193\u2013201","journal-title":"Dialogues Clin Neurosci"},{"key":"9161_CR210","doi-asserted-by":"crossref","unstructured":"Post RM (2010) Mechanisms of illness progression in the recurrent affective disorders. Neurotoxicity Res (in press)","DOI":"10.1007\/s12640-010-9182-2"},{"key":"9161_CR211","first-page":"1181","volume":"18","author":"RM Post","year":"2006","unstructured":"Post RM, Leverich GS (2006) The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol 18:1181\u20131211","journal-title":"Dev Psychopathol"},{"key":"9161_CR212","doi-asserted-by":"crossref","unstructured":"Pukrop R, Klosterk\u00f6tter J (2010) Neurocognitive indicators of clinical high-risk states for psychosis: a critical review of the evidence. Neurotoxicity Res (in press)","DOI":"10.1007\/s12640-010-9191-1"},{"key":"9161_CR213","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2007.01.020","volume":"92","author":"R Pukrop","year":"2007","unstructured":"Pukrop R, Ruhrmann S, Schultze-Lutter F, Bechdolf A, Brockhaus-Dumke A, Klosterk\u00f6tter J (2007) Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res 92:116\u2013125","journal-title":"Schizophr Res"},{"key":"9161_CR214","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0165-0327(02)00091-5","volume":"72","author":"S Quraishi","year":"2002","unstructured":"Quraishi S, Frangou S (2002) Neuropsychology of bipolar disorder: a review. J Affect Disord 72:209\u2013226","journal-title":"J Affect Disord"},{"key":"9161_CR215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.phrs.2009.03.006","volume":"60","author":"N Realini","year":"2009","unstructured":"Realini N, Rubino T, Parolaro D (2009) Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol Res 60:132\u2013138","journal-title":"Pharmacol Res"},{"key":"9161_CR216","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1176\/appi.ajp.2009.09020279","volume":"166","author":"DA Regier","year":"2009","unstructured":"Regier DA, Narrow WE, Kuhl EA, Kupfer DJ (2009) The conceptual development of DSM-V. Am J Psychiatr 166:645\u2013650","journal-title":"Am J Psychiatr"},{"key":"9161_CR219","unstructured":"Reid IC, Cameron IM (2010) The HEAT is on: demonizing antidepressant drugs in Scotland (in press)"},{"key":"9161_CR220","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-5618.2008.00588.x","volume":"10","author":"M Reinares","year":"2008","unstructured":"Reinares M, Colom F, S\u00e1nchez-Moreno J, Torrent C, Mart\u00ednez-Ar\u00e1n A, Gomes M, Goikolea JM, Benabarre A, Salamero M, Vieta E (2008) Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. Bipolar Disord 10:511\u2013519","journal-title":"Bipolar Disord"},{"key":"9161_CR221","unstructured":"Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sol\u00e9 B, Kapczinski F, Vieto E (2009) The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disorder. PMID:19853922"},{"key":"9161_CR222","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.mp.4001495","volume":"9","author":"C Reist","year":"2004","unstructured":"Reist C, Mazzanti C, Vu R, Fujimoto K, Goldman D (2004) Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5.HT2A candidate allelle: His452Tyr. Mol Psychiatr 9:871\u2013878","journal-title":"Mol Psychiatr"},{"key":"9161_CR223","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0447.2006.00854.x","volume":"115","author":"A Riecher-R\u00f6ssler","year":"2007","unstructured":"Riecher-R\u00f6ssler A, Gschwandtner U, Aston J, Borgwardt S, Drewe M, Fuhr P, Pfl\u00fcger M, Rad\u00fc W, Schindler Ch, Stieglitz RD (2007) The Basel early-detection-of-psychosis (FEPSY)-study\u2014design and preliminary results. Acta Psychiat Scand 115:114\u2013125","journal-title":"Acta Psychiat Scand"},{"key":"9161_CR217","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0447.2005.00722.x","volume":"113","author":"A Riecher-R\u00f6ssler","year":"2006","unstructured":"Riecher-R\u00f6ssler A, Gschwander U, Borgwardt SJ, Aston J, Pfl\u00fcger M, R\u00f6ssler W (2006) Early detection and treatment of schizophrenia: how early? Acta Psychiatr Scand 113:73\u201380","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR224","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.biopsych.2009.07.020","volume":"66","author":"A Riecher-R\u00f6ssler","year":"2009","unstructured":"Riecher-R\u00f6ssler A, Pflueger MO, Aston J, Borgwardt SJ, Brewer WJ, Gschwandtner U, Stieglitz RD (2009) Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 66:1023\u20131030","journal-title":"Biol Psychiatry"},{"key":"9161_CR225","unstructured":"Riemer S, Maes M, Christophe A, Rief W (2009) Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord. PMID:19720401"},{"key":"9161_CR226","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/gps.755","volume":"17","author":"PH Robert","year":"2002","unstructured":"Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Broker P, Bedoucha P (2002) The apathy inventory: assessment of apathy and awareness in Alzheimer\u2019s disease, Parkinson\u2019s disease and mild cognitive impairment. Int J Geriatr Psychiatr 17:1099\u20131105","journal-title":"Int J Geriatr Psychiatr"},{"key":"9161_CR227","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2008.09.001","volume":"24","author":"PH Robert","year":"2009","unstructured":"Robert PH, Onyike CU, Leentjens AF, Dujardin K, Aalten P, Starkstein S, Verhey FR, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J (2009) Proposed diagnostic criteria for apathy in Alzheimer\u2019s disease and other neuropsychiatric disorders. Eur Psychiatry 24:98\u2013104","journal-title":"Eur Psychiatry"},{"key":"9161_CR228","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-5618.2006.00277.x","volume":"8","author":"LJ Robinson","year":"2006","unstructured":"Robinson LJ, Ferrier IN (2006) Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8:103\u2013116","journal-title":"Bipolar Disord"},{"key":"9161_CR229","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","volume":"56","author":"D Robinson","year":"1999","unstructured":"Robinson D, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatr 56:241\u2013247","journal-title":"Arch Gen Psychiatr"},{"key":"9161_CR230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/schbul\/sbi032","volume":"31","author":"D Robinson","year":"2005","unstructured":"Robinson D, Woerner MG, Delman HM, Kane JM (2005) Pharmacological treatments for first episode schizophrenia. Schizophr Bull 31:705\u2013722","journal-title":"Schizophr Bull"},{"key":"9161_CR231","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1041610209990354","volume":"21","author":"J Rodda","year":"2009","unstructured":"Rodda J, Morgan S, Walker Z (2009) Are cholinesterase inhibitors effective in the management of the behavioural and psychological symptoms of dementia in Alzheimer\u2019s disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Int Psychogeriatr 21:813\u2013824","journal-title":"Int Psychogeriatr"},{"key":"9161_CR232","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000151520","volume":"77","author":"AR Rosa","year":"2008","unstructured":"Rosa AR, Franco C, Mart\u00ednez-Aran A, S\u00e1nchez-Moreno J, Reinares M, Salamero M, Arango C, Ayuso-Mateos JL, Kapczinski F, Vieta E (2008) Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom 77:390\u2013392","journal-title":"Psychother Psychosom"},{"key":"9161_CR233","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-5618.2009.00698.x","volume":"11","author":"AR Rosa","year":"2009","unstructured":"Rosa AR, Reinares M, Franco C, Comes M, Torrent C, S\u00e1nchez-Moreno J, Mart\u00ednez-Ar\u00e1n A, Salamero M, Kapczinski F, Vieta E (2009) Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord 11:401\u2013409","journal-title":"Bipolar Disord"},{"key":"9161_CR234","first-page":"13","volume":"4","author":"DR Royall","year":"1999","unstructured":"Royall DR (1999) Frontal systems impairment in major depression. Semin Clin Neuropsychiatr 4:13\u201323","journal-title":"Semin Clin Neuropsychiatr"},{"key":"9161_CR235","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1532-5415.1992.tb03646.x","volume":"40","author":"DR Royall","year":"1992","unstructured":"Royall DR, Mahurin RK, Gray K (1992) Bedside assessment of executive cognitive impairment: The Executive Interview (EXIT). J Am Geriatr Soc 40:1221\u20131226","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl. 3","key":"9161_CR236","first-page":"S162","volume":"36","author":"S Ruhrmann","year":"2003","unstructured":"Ruhrmann S, Schultz-Lutter F, Klosterkotter J (2003) Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiat 36(Suppl. 3):S162\u2013S167","journal-title":"Pharmacopsychiat"},{"key":"9161_CR237","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0447.2008.01152.x","volume":"117","author":"S Ruhrmann","year":"2008","unstructured":"Ruhrmann S, Paruch J, Bechdolf A, Pukrop R, Wagner M, Berning J, Schultze-Lutter F, Janssen B, Gaebel W, M\u00f6ller HJ, Maier W, Klosterk\u00f6tter J (2008) Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr Scand 117:357\u2013368","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR238","unstructured":"Rummel C, Hamann J, Kissling W, Leucht S (2003) New generation antipsychotics for first episode schizophrenia. Cochrane Database Syst Rev CD004410"},{"key":"9161_CR239","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0447.2005.00626.x","volume":"113","author":"BR Rund","year":"2006","unstructured":"Rund BR, Sundet K, Asbj\u00f8rnsen A, Egeland J, Landr\u00f8 NI, Lund A, Roness A, Stordal KI, Hugdahl K (2006) Neuropsychological test profiles in schizophrenia and non-psychotic depression. Acta Psychiatr Scand 113:350\u2013359","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR240","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/(SICI)1099-1166(199912)14:12<1031::AID-GPS59>3.0.CO;2-V","volume":"14","author":"P Saz","year":"1999","unstructured":"Saz P, Launer LJ, D\u00eda JL, De-La-C\u00e1mara C, Marcos G, Lobo A (1999) Mortality and mental disorders in a Spanish elderly population. Int J Geriatr Psychiatry 14:1031\u20131038","journal-title":"Int J Geriatr Psychiatry"},{"key":"9161_CR241","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0447.2008.01280.x","volume":"119","author":"P Saz","year":"2009","unstructured":"Saz P, L\u00f3pez-Ant\u00f3n R, Dewey ME, Ventura T, Mart\u00edn A, Marcos G, De La C\u00e1mara C, Quintanilla MA, Quetglas B, Bel M, Barrera A, Lobo A (2009) Prevalence and implications of psychopathological non-cognitive symptoms in dementia. Acta Psychiatr Scand 119:107\u2013116","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR242","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","volume":"22","author":"A Schrag","year":"2007","unstructured":"Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG (2007) Depression rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 22:1077\u20131092","journal-title":"Mov Disord"},{"key":"9161_CR243","first-page":"310","volume":"188","author":"J Scott","year":"2006","unstructured":"Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomized controlled trial. Br J Psychiatr 188:310\u2013320","journal-title":"Br J Psychiatr"},{"key":"9161_CR244","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2190\/PM.39.1.d","volume":"39","author":"H Sheikholeslami","year":"2009","unstructured":"Sheikholeslami H, Kani C, Kani K, Ghafelebashi H (2009) Repetition of suicide-related behavior: a study of the characteristics, psychopathology, suicidality and negative life events in Iran. Int J Psychiatry Med 39:45\u201362","journal-title":"Int J Psychiatry Med"},{"key":"9161_CR245","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jpsychires.2008.09.005","volume":"43","author":"YC Shen","year":"2009","unstructured":"Shen YC, Chen SF, Chen CH, Lin CC, Chen SJ, Chen YJ, Luu SU (2009) Effects of DRD2\/ANKKI gene variations and clinical factors on aripipazole efficacy in schizophrenic patients. J Psychiatric Res 43:600\u2013606","journal-title":"J Psychiatric Res"},{"key":"9161_CR246","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2990.2009.01038.x","volume":"35","author":"G Simic","year":"2009","unstructured":"Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR (2009) Does Alzheimer\u2019s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532\u2013554","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9161_CR247","first-page":"9","volume":"12","author":"S Simpson","year":"2009","unstructured":"Simpson S, Barnes E, Griffiths E, Hood K, Cohen D, Craddock N, Jones I, Smith DJ (2009) The Bipolar Interactive Psychoeducation (BIPED) study: trial design and protocol. BMC Psychiatry 12:9\u201350","journal-title":"BMC Psychiatry"},{"key":"9161_CR248","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/138161209788957456","volume":"15","author":"R Smieskova","year":"2009","unstructured":"Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Rad\u0171 EW, McGuire PK, Riecher-R\u00f6ssler A, Borgwardt SJ (2009) The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?\u2014a systematic review. Curr Pharm Des 15:2535\u20132549","journal-title":"Curr Pharm Des"},{"key":"9161_CR249","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.mp.4000342","volume":"3","author":"G Spurlock","year":"1998","unstructured":"Spurlock G, Heils A, Holmans P, Williams J, D\u2019Souza UM, Cardno A, Murphy KC, Jones L, Buckland PR, McGuffin P, Lesch KP, Owen MJ (1998) A family based association study of T102C polymorphism in 5-HT2A and schizophrenia plus identification of new polymorphisms in the promotor. Mol Psychiatr 3:42\u201349","journal-title":"Mol Psychiatr"},{"issue":"Suppl 1","key":"9161_CR250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1041610200006918","volume":"12","author":"SE Starkstein","year":"2000","unstructured":"Starkstein SE (2000) Apathy and withdrawal. Int Psychogeriatr 12(Suppl 1):135\u2013138","journal-title":"Int Psychogeriatr"},{"key":"9161_CR251","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp.2007.136895","volume":"79","author":"SE Starkstein","year":"2008","unstructured":"Starkstein SE, Leentjens AF (2008) The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatr 79:1088\u20131092","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"9161_CR252","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"SE Starkstein","year":"1992","unstructured":"Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leisguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 4:134\u2013139","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR253","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4321\/S0213-61632006000200005","volume":"20","author":"SE Starkstein","year":"2006","unstructured":"Starkstein SE, Jorge R, Mizrahi R (2006) The prevalence, clinical correlates and treatment of apathy in Alzheimer\u2019s disease. Eur J Psychiatr 20:96\u2013106","journal-title":"Eur J Psychiatr"},{"key":"9161_CR254","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/jama.283.16.2091","volume":"283","author":"J Stephenson","year":"2000","unstructured":"Stephenson J (2000) Delay in treating schizophrenia may narrow therapeutic window of opportunity. JAMA 283:2091\u20132092","journal-title":"JAMA"},{"key":"9161_CR255","unstructured":"Stewart T, Goulding SM, Esterberg ML, Pringle M, Compton MT (2010)"},{"key":"9161_CR256","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/PSY.0b013e31819082ef","volume":"71","author":"S Su","year":"2009","unstructured":"Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, Jones L, Murrah NV, Goldberg J, Vaccarino V (2009) Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med 71:152\u2013158","journal-title":"Psychosom Med"},{"key":"9161_CR257","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1017\/S0033291706008804","volume":"36","author":"M Summers","year":"2006","unstructured":"Summers M, Papadopoulou K, Bruno S, Cipol L, Ron MA (2006) Bipolar I and Bipolar II disorder: cognition and emotion processing. Psychol Med 36:1799\u20131809","journal-title":"Psychol Med"},{"key":"9161_CR258","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.schres.2008.06.021","volume":"105","author":"T Takahashi","year":"2008","unstructured":"Takahashi T, Yung AR, Y\u00fccel M, Wood SJ, Phillips LJ, Harding IH, Soulsby B, McGorry PD, Suzuki M, Velakoulis D, Pantelis C (2008) Prevalence of large cavum septi pellucidi in ultra high-risk individuals and patients with psychotic disorders. Schizophr Res 105:236\u2013244","journal-title":"Schizophr Res"},{"key":"9161_CR259","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2009.03.024","volume":"111","author":"T Takahashi","year":"2009","unstructured":"Takahashi T, Wood SJ, Yung AR, Phillips LJ, Soulsby B, McGorry PD, Tanino R, Zhou SY, Suzuki M, Velakoulis D, Pantelis C (2009) Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res 111:94\u2013102","journal-title":"Schizophr Res"},{"key":"9161_CR260","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneurol.2009.117","volume":"5","author":"E Taylor","year":"2009","unstructured":"Taylor E (2009) Managing bipolar disorders in children and adolescents. Nat Rev Neurol 5:484\u2013491","journal-title":"Nat Rev Neurol"},{"key":"9161_CR261","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/NMD.0b013e3181b3b152","volume":"197","author":"S Therman","year":"2009","unstructured":"Therman S, Suvisaari JM, Kalska H, Huttunen MO, Manninen M, Cannon TD (2009) Lack of association between neuropsychological performance and level of psychosis-proneness in an adolescent psychiatric sample. J Nerv Ment Dis 197:669\u2013674","journal-title":"J Nerv Ment Dis"},{"key":"9161_CR262","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/bjp.bp.105.017269","volume":"189","author":"C Torrent","year":"2006","unstructured":"Torrent C, Mart\u00ednez-Ar\u00e1n A, Daban C, S\u00e1nchez-Moreno J, Comes M, Goikolea JM, Salamero M, Vieta E (2006) Cognitive impairment in bipolar II disorder. Br J Psychiatr 189:254\u2013259","journal-title":"Br J Psychiatr"},{"key":"9161_CR263","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1600-0447.2007.01072.x","volume":"116","author":"C Torrent","year":"2007","unstructured":"Torrent C, Mart\u00ednez-Ar\u00e1n A, Amann B, Daban C, Tabar\u00e9s-Seisdedos R, Gonz\u00e1lez-Pinto A, Reinares M, Benabarre A, Salamero M, McKenna P, Vieta E (2007) Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr Scand 116:453\u2013460","journal-title":"Acta Psychiatr Scand"},{"key":"9161_CR264","first-page":"67","volume":"17","author":"S Uzun","year":"2005","unstructured":"Uzun S, Kozumplik O, Mimica N, Folnegovic-Smalc V (2005) Aripipazole: an overview of a novel antipsychotic. Psychiatr Danub 17:67\u201375","journal-title":"Psychiatr Danub"},{"key":"9161_CR265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.biopsych.2008.04.023","volume":"64","author":"V Vaccarino","year":"2008","unstructured":"Vaccarino V, Brennan ML, Miller AH, Bremner JD, Ritchie JC, Lindau F, Veledar E, Su S, Jones L, Jawed F, Dai J, Goldberg J, Hazen SL (2008a) Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 64:476\u2013483","journal-title":"Biol Psychiatry"},{"key":"9161_CR266","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/PSY.0b013e31817bcc9e","volume":"70","author":"V Vaccarino","year":"2008","unstructured":"Vaccarino V, Lampert R, Bremner JD, Lee F, Su S, Maisano C, Murrah NV, Jones L, Jawed F, Afzal N, Ashraf A, Goldberg J (2008b) Depressive symptoms and heart rate variability: evidence for a shared genetic substrate in a study of twins. Psychosom Med 70:628\u2013636","journal-title":"Psychosom Med"},{"key":"9161_CR267","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/archinternmed.2009.330","volume":"169","author":"V Vaccarino","year":"2009","unstructured":"Vaccarino V, Votaw J, Faber T, Veledar E, Murrah NV, Jones LR, Zhao J, Su S, Goldberg J, Raggi JP, Quyyumi AA, Sheps DS, Bremner JD (2009) Major depression and coronary flow reserve detected by positron emission tomography. Arch Intern Med 169:1668\u20131676","journal-title":"Arch Intern Med"},{"key":"9161_CR268","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.neuropsych.19.4.441","volume":"19","author":"E Duijn Van","year":"2007","unstructured":"Van Duijn E, Kingma EM, van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19:441\u2013448","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR269","unstructured":"Vieta E, Popovic D, Rosa AR, Sol\u00e9 B, Grande I, Frey BN, Martinez-Aran A, Kaczinski F (2009) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. J Clin Psychiatr (in press). PMID:19906078"},{"key":"9161_CR270","doi-asserted-by":"crossref","unstructured":"Vieta E, Reinares M, Rosa AR (2010) Staging bipolar disorder. Neuroyoxicity Res (in press)","DOI":"10.1007\/978-1-4614-0785-0_6"},{"key":"9161_CR297","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.162.2.401","volume":"162","author":"D Wade","year":"2005","unstructured":"Wade D (2005) Cannabis use and schizophrenia. Am J Psychiatr 162:401\u2013402","journal-title":"Am J Psychiatr"},{"key":"9161_CR271","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10942-009-0098-9","volume":"27","author":"ER Watkins","year":"2009","unstructured":"Watkins ER (2009) Depressive rumination and co-morbidity: evidence for brooding as a transdiagnostic process. J Ration Emot Cogn Behav Ther 27:160\u2013175","journal-title":"J Ration Emot Cogn Behav Ther"},{"key":"9161_CR272","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","volume":"21","author":"PJ Weiden","year":"1995","unstructured":"Weiden PJ, Olfson M (1995) Cost of relapse in schizophrenia. Schizophr Bull 21:419\u2013429","journal-title":"Schizophr Bull"},{"key":"9161_CR273","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1532-5415.2004.52219.x","volume":"52","author":"D Weintraub","year":"2004","unstructured":"Weintraub D, Moberg PJ, Duda JE, Katz IR, Stren MB (2004) Effect of psychiatric and other nonmotor symptoms on disability in Parkinson\u2019s disease. J Am Geriatr Soc 52:784\u2013789","journal-title":"J Am Geriatr Soc"},{"key":"9161_CR274","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a033315","volume":"24","author":"D Wiersma","year":"1998","unstructured":"Wiersma D, Nienhuis FJ, Slooff CJ, Giel R (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 24:75\u201385","journal-title":"Schizophr Bull"},{"key":"9161_CR298","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archneurol.2009.69","volume":"66","author":"MM Williams","year":"2009","unstructured":"Williams MM, Roe CM, Morris JC (2009) Stability of the Clinical Dementia Rating, 1979\u20132007. Arch Neurol 66:773\u2013777","journal-title":"Arch Neurol"},{"key":"9161_CR275","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1176\/appi.neuropsych.18.3.397","volume":"18","author":"K Witt","year":"2006","unstructured":"Witt K, Daniels C, Herzog J, Lorenz D, Volkmann J, Reiff J, Mehdorn M, Deuschl G, Krack P (2006) Differential effects of l-Dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 18:397\u2013401","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9161_CR276","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pscychresns.2008.08.002","volume":"173","author":"H Witthaus","year":"2009","unstructured":"Witthaus H, Kaufmann C, Bohner G, \u00d6zg\u0171rdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Br\u0171ne M, Heinz A, Klingebiel R, Juckel G (2009) Gray matter abnormalities in subjects at high-risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatr Res 173:163\u2013169","journal-title":"Psychiatr Res"},{"issue":"4 Suppl","key":"9161_CR277","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.5694\/j.1326-5377.2009.tb02367.x","volume":"190","author":"SJ Wood","year":"2009","unstructured":"Wood SJ, Pantelis C, Yung AR, Velakoulis D, McGorry PD (2009) Brain changes during the onset of schizophrenia: implications for neurodevelopmental theories. Med J Aust 190(4 Suppl):S10\u2013S13","journal-title":"Med J Aust"},{"key":"9161_CR278","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S1461145708009449","volume":"12","author":"LN Yathan","year":"2009","unstructured":"Yathan LN, Kapczinski F, Andreazza AC, Young TL, Lam RW, Kauer-Sant\u2019anna M (2009) Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 12:137\u2013139","journal-title":"Int J Neuropsychopharmacol"},{"key":"9161_CR279","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000054871","volume":"43","author":"YW Yu","year":"2001","unstructured":"Yu YW, Tsai SJ, Yang KH, Lin CH, Chen MC, Hong CJ (2001) Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T\/C) and increment of N100 amplitude in schizophrenics treated with clozapine. Neuropsychobiology 43:79\u201382","journal-title":"Neuropsychobiology"},{"key":"9161_CR280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1192\/S0007125000297602","volume":"172","author":"AR Yung","year":"1998","unstructured":"Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ (1998) Prediction of psychosis: a step towards indicated prevention of schizophrenia. Br J Psychiat Suppl 172:14\u201320","journal-title":"Br J Psychiat Suppl"},{"key":"9161_CR281","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0920-9964(03)00192-0","volume":"67","author":"AR Yung","year":"2004","unstructured":"Yung AR, Phillips LJ, Yuen HP, McGorry PD (2004) Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67:131\u2013142","journal-title":"Schizophr Res"},{"key":"9161_CR282","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2008.07.012","volume":"105","author":"AR Yung","year":"2008","unstructured":"Yung AR, Nelson B, Stanford C, Simmons NB, Cosgrave EM, Killackey E, Phillips LJ, Bechdolf A, Buckby J, McGorry PD (2008) Validation of \u201cprodromal\u201d criteria to detect individuals at ultra high risk of psychosis: 2\u00a0year follow-up. Schizophr Res 105:10\u201317","journal-title":"Schizophr Res"},{"key":"9161_CR283","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/00048670802607188","volume":"43","author":"AR Yung","year":"2009","unstructured":"Yung AR, Nelson B, Baker K, Buckby JA, Baksheev G, Cosgrave EM (2009) Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust NZ J Psychiat 43:118\u2013128","journal-title":"Aust NZ J Psychiat"},{"key":"9161_CR284","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mds.22441","volume":"24","author":"LB Zahodne","year":"2009","unstructured":"Zahodne LB, Young S, Kirsch-Darrow L, Nisenzon A, Fernandez HH, Okun MS, Bowers (2009) Examination of the Lille Apathy Rating Scale in Parkinson\u2019s disease. Mov Disord 24:677\u2013683","journal-title":"Mov Disord"},{"key":"9161_CR285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1192\/bjp.bp.107.046375","volume":"193","author":"S Zammit","year":"2008","unstructured":"Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatr 193:357\u2013363","journal-title":"Br J Psychiatr"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-010-9161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-010-9161-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-010-9161-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:47:57Z","timestamp":1685494077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-010-9161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":290,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["9161"],"URL":"https:\/\/doi.org\/10.1007\/s12640-010-9161-7","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}